Viewing StudyNCT00231166



Ignite Creation Date: 2024-05-05 @ 12:05 PM
Last Modification Date: 2024-10-26 @ 9:19 AM
Study NCT ID: NCT00231166
Status: COMPLETED
Last Update Posted: 2018-10-11
First Post: 2005-09-30

Brief Title: Safety Efficacy Dose-finding Study of a Monoclonal Antibody in Patients With Multiple Myeloma
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Multiple Myeloma
Keywords:
Name View
Multiple Myeloma View
dose-finding View
monoclonal antibody View